Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.14)
# 2,797
Out of 4,761 analysts
285
Total ratings
57.58%
Success rate
-0.69%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HIMS Hims & Hers Health | Downgrades: Equal-Weight | $42 → $60 | $49.28 | +21.75% | 2 | Feb 18, 2025 | |
| ARDT Ardent Health Partners | Maintains: Overweight | $24 → $22 | $13.90 | +58.27% | 2 | Jan 21, 2025 | |
| VEEV Veeva Systems | Maintains: Underweight | $183 → $195 | $225.79 | -13.64% | 6 | Dec 17, 2024 | |
| AMWL American Well | Maintains: Equal-Weight | $20 → $11 | $11.74 | -10.56% | 5 | Dec 17, 2024 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $7 → $6 | $4.81 | +24.74% | 2 | Dec 17, 2024 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $406 → $355 | $316.42 | +12.19% | 2 | Dec 17, 2024 | |
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $123 → $97 | $155.33 | -37.55% | 14 | Nov 5, 2024 | |
| DH Definitive Healthcare | Maintains: Equal-Weight | $9 → $5 | $4.92 | +1.63% | 12 | Aug 6, 2024 | |
| SWKS Skyworks Solutions | Maintains: Equal-Weight | $96 → $114 | $67.21 | +69.62% | 24 | Feb 7, 2023 | |
| ST Sensata Technologies Holding | Maintains: Overweight | $62 → $57 | $29.49 | +93.29% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $61.07 | +32.63% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $72.37 | -51.64% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $14.82 | +21.46% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $76.07 | +143.20% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $154.51 | +8.08% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $67.58 | -37.85% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $172.24 | -7.69% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $63.48 | +96.91% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $218.66 | -66.93% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $202.00 | -3.47% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $466.42 | +4.63% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $283.81 | +4.30% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $249.85 | +47.29% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $255.91 | +100.46% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $299.81 | -8.28% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $57.68 | +52.57% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $54.05 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $71.76 | +157.80% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $236.52 | -9.94% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $96.75 | -40.05% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $238.91 | -51.03% | 15 | Jun 16, 2020 |
Hims & Hers Health
Feb 18, 2025
Downgrades: Equal-Weight
Price Target: $42 → $60
Current: $49.28
Upside: +21.75%
Ardent Health Partners
Jan 21, 2025
Maintains: Overweight
Price Target: $24 → $22
Current: $13.90
Upside: +58.27%
Veeva Systems
Dec 17, 2024
Maintains: Underweight
Price Target: $183 → $195
Current: $225.79
Upside: -13.64%
American Well
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $20 → $11
Current: $11.74
Upside: -10.56%
GoodRx Holdings
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $7 → $6
Current: $4.81
Upside: +24.74%
HCA Healthcare
Dec 17, 2024
Maintains: Equal-Weight
Price Target: $406 → $355
Current: $316.42
Upside: +12.19%
Silicon Laboratories
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $123 → $97
Current: $155.33
Upside: -37.55%
Definitive Healthcare
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $4.92
Upside: +1.63%
Skyworks Solutions
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $67.21
Upside: +69.62%
Sensata Technologies Holding
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $29.49
Upside: +93.29%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $61.07
Upside: +32.63%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $72.37
Upside: -51.64%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $14.82
Upside: +21.46%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $76.07
Upside: +143.20%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $154.51
Upside: +8.08%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $67.58
Upside: -37.85%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $172.24
Upside: -7.69%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $63.48
Upside: +96.91%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $218.66
Upside: -66.93%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $202.00
Upside: -3.47%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $466.42
Upside: +4.63%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $283.81
Upside: +4.30%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $249.85
Upside: +47.29%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $255.91
Upside: +100.46%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $299.81
Upside: -8.28%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $57.68
Upside: +52.57%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $54.05
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $71.76
Upside: +157.80%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $236.52
Upside: -9.94%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $96.75
Upside: -40.05%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $238.91
Upside: -51.03%